
Conference Coverage
about 4 hours ago
Vienna calling: Inside the 26th EURETINA Congressabout 11 hours ago
ESCRS 2026: Building respectful, inclusive workplaces in ophthalmologyTrending on the Eye Care Network
RCA releases first State of Retina Care report
FAQ: What retina specialists need to know about the MOGENRY (MCO-010) BLA acceptance
OT Roundup ep. 1: ADHD's eye link, MOGENRY's BLA, and myopia news
Linsitinib phase 3 ORBIT trial doses first patients for thyroid eye disease
FDA highlights in ophthalmology: third quarter 2026
Latest News

Vienna calling: Inside the 26th EURETINA Congress

RCA releases first State of Retina Care report

FAQ: What retina specialists need to know about the MOGENRY (MCO-010) BLA acceptance

Linsitinib phase 3 ORBIT trial doses first patients for thyroid eye disease

FDA highlights in ophthalmology: third quarter 2026

Shorts










Digital Edition








Podcasts
Continuing Medical Education
All News

After four years and 500+ office-based procedures, Johnathan Feistmann, MD, shares how the model shortened time to surgery for fovea-threatening cases while reshaping patient experience and practice workflow.

Atrial fibrillation appears to cause thinning of the macular ganglion cell and inner plexiform layer.

Influence on effective lens position in cataract and lens-based surgery.

Benjamin Bakall, MD, PhD, weighs the RESTORE efficacy and safety data, the practical realities of in-office delivery, and how genotype-independent treatment reshapes candidacy and patient counseling.

Bausch + Lomb's SeeLyra femtosecond laser platform, featuring live OCT imaging, has received CE mark approval for cataract, LASIK, and corneal procedures in Europe.

The authors of a review of 16 gene therapy trials for inherited retinal diseases explain why the pediatric evidence base remains thin and argue that individual-level, age-stratified reporting is the change most needed before CRISPR-based editing reaches children.

Majda Hadziahmetovic, MD, on MacTel neovascular warning signs, urgent referral, and how Encelto reshapes screening.

AMA resolution backs classifying myopia as a disease, aiming to expand insurance coverage for pediatric myopia control treatments.

In patients reporting chronic ocular pain, dry eye may not be the entire diagnosis.

Polish investigators showed that various modalities can quantify ocular changes in attention deficit/hyperactivity disorder.

Mingo-Botín, MD, PhD, discusses ESCRS 2026 data on an EDOF IOL in post-LASIK eyes vs non-LASIK controls.

The 44th Congress of the ESCRS kicked off at ExCeL London with iNovation Day and the Opening Ceremony, setting the stage for a five-day programme.

Opus Genetics announced positive 3- and 6-month results OPGx-BEST1 in BEST1-related retinal diseases.

A JAMA Ophthalmology Clinical Trial of the Year enrolled 1421 eyes across 28 sites, with NEI-funded follow-up extending the findings to 5 years.

Handheld IC1000 pairs rebound tonometry with camera-guided alignment




















